Lin Michelle P, Sanossian Nerses
Department of Neurology, University of Southern California, Los Angeles, CA 90033, USA.
Department of Neurology, University of Southern California, Los Angeles, CA 90033, USA; Department of Neurology, Roxanna Todd Hodges Comprehensive Stroke Clinic, University of Southern California, 1520 San Pablo Street, Suite 3000, Los Angeles, CA 90026, USA.
Cardiol Clin. 2015 Feb;33(1):99-109. doi: 10.1016/j.ccl.2014.09.009.
Reperfusion, or restoration of blood flow, is an effective means of reducing disability in the setting of acute stroke. Reperfusion therapies, such as intravenous thrombolysis or endovascular and interventional procedures, fit within the existing stroke system of care. There are currently 4 devices cleared by the Food and Drug Administration for recanalization of arterial occlusion in patients with ischemic stroke. Endovascular device technology and advanced imaging technology continue to evolve with newer devices suggesting greater recanalization success. A new paradigm using advanced imaging to select patients in combination with newer devices is being tested and may lead to great improvements in care.
再灌注，即血流恢复，是降低急性中风致残率的有效手段。再灌注疗法，如静脉溶栓或血管内介入手术，符合现有的中风护理体系。目前，美国食品药品监督管理局已批准4种用于缺血性中风患者动脉闭塞再通的设备。血管内设备技术和先进成像技术不断发展，新设备显示出更高的再通成功率。一种结合先进成像技术选择患者并使用新设备的新模式正在进行测试，可能会带来护理方面的巨大改善。
